Real-World Use of Oritavancin for the Treatment of Osteomyelitis

MLA

Patrick J. Scoble, et al. “Real-World Use of Oritavancin for the Treatment of Osteomyelitis.” Drugs - Real World Outcomes, vol. 7, no. S1, June 2020, pp. 46–54. EBSCOhost, https://doi.org/10.1007/s40801-020-00194-8.

APA

Patrick J. Scoble, Joseph Reilly, & Glenn S. Tillotson. (2020). Real-World Use of Oritavancin for the Treatment of Osteomyelitis. Drugs - Real World Outcomes, 7(S1), 46–54. https://doi.org/10.1007/s40801-020-00194-8

Chicago

Patrick J. Scoble, Joseph Reilly, and Glenn S. Tillotson. 2020. “Real-World Use of Oritavancin for the Treatment of Osteomyelitis.” Drugs - Real World Outcomes 7 (S1): 46–54. doi:10.1007/s40801-020-00194-8.